Crystal ball planning for analytics implementation in Singapore

Amgen is building a new drug substance manufacturing site in Singapore (ASM). This project identified and mitigated the risks associated with implementing analytical technologies to facilitate the design and implementation of the quality control process in the new plant. Here, a systematic risk evaluation model was established to identify sources of high risks from implementing the analytical technologies in ASM, evaluated business cases and proposed technical strategies for risk mitigation. This project also included a case study about the cross-functional initiatives at Amgen, and made recommendations regarding how to bridge the gaps between the technology development in R&D and the technology implementation in manufacturing sites.

Department dc:contributor.department

Leaders for Global Operations Program at MIT

Grantor dc:publisher

Massachusetts Institute of Technology

Year dc:date.issued

2014

Author dc:creator

• Fang, Cong, Ph.D. California State University, Los Angeles

Advisor dc:contributor.advisor

• Peter C. Dedon and Roy E. Welsch.

• Sloan School of Management.
• Biological Engineering.
• Leaders for Global Operations Program.

Statement dc:rights

• MIT theses may be protected by copyright. Please reuse MIT thesis content according to the MIT Libraries Permissions Policy, which is available through the URL provided.

Licence dc:rights.uri

• http://dspace.mit.edu/handle/1721.1/7582

Language dc:language.iso

eng

Handle dc:identifier.uri

http://hdl.handle.net/1721.1/90802

OAI identifier oai:identifier

oai:dspace.mit.edu:1721.1/90802